Jupiter Neurosciences has approved a 1-for-75 reverse stock split of its common stock, effective after the market closes on August 6, 2026. The move, backed by shareholders at the July 22 annual meeting, aims to increase the per-share trading price and help the company regain compliance with Nasdaq's minimum bid price requirement. Trading on a split-adjusted basis will begin August 7 under the ticker JUNS and a new CUSIP number, reducing outstanding shares from approximately 57.76 million as of August 4 to about 770,081 shares. No fractional shares will be issued; instead, holders will receive cash payments based on the August 6 closing price. The stock is currently trading at $0.07, down 25%.
Jupiter Neurosciences, Inc. Common StockReverse stock split aims to boost share price and regain Nasdaq compliance, but current trading at $0.07 down 25% suggests mixed market reaction.
